Cutler Group’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-45
Closed -$44K 4996
2019
Q1
$44K Buy
45
+20
+80% +$8.07K ﹤0.01% 1520
2018
Q4
$29K Buy
+25
New +$19.4K ﹤0.01% 1851
2018
Q3
Sell
-19
Closed -$12K 4925
2018
Q2
$12K Hold
19
﹤0.01% 2565
2018
Q1
$8K Sell
19
-17
-47% -$18.8K ﹤0.01% 2994
2017
Q4
$19K Sell
36
-1
-3% -$924 ﹤0.01% 2618
2017
Q3
$5K Sell
37
-299
-89% -$340K ﹤0.01% 4459
2017
Q2
$37K Buy
336
+70
+26% +$85.2K ﹤0.01% 2795
2017
Q1
$30K Sell
266
-19
-7% -$18.3K ﹤0.01% 2918
2016
Q4
$21K Buy
+285
New +$129K ﹤0.01% 3450
2016
Q3
Sell
-60
Closed -$33K 7620
2016
Q2
$33K Sell
60
-6
-9% -$2.94K ﹤0.01% 2809
2016
Q1
$37K Sell
66
-36
-35% -$13.9K ﹤0.01% 2645
2015
Q4
$69K Buy
+102
New +$71.5K ﹤0.01% 2131

Other funds holding HSTO

Cutler Group's HSTO Position: Q2 2019 in Review

Cutler Group sold out of Histogen Inc. Common Stock (HSTO) in Q2 2019, closing a stake of 44 shares — an estimated $9K sold.

Cutler Group first reported a position in HSTO in Q4 2015 and held it in 14 quarters. The position peaked at $128K in Q2 2017. 36 funds tracked by Wall St. Rank hold HSTO as of Q2 2019.

  • Cutler Group reported no remaining Histogen Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Cutler Group sold 44 Histogen Inc. Common Stock shares in Q2 2019, an estimated $9K.
  • Cutler Group first reported a position in Histogen Inc. Common Stock in Q4 2015 and held it in 14 quarters.
  • Cutler Group's Histogen Inc. Common Stock position peaked at $128K in Q2 2017.
  • 36 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2019.

Based on Cutler Group's 13F filing for Q2 2019, filed 9 Aug 2019.